Pre-market hot trades in US stocks: Rising Dragon Acquisition pre-market down 24.82%; Viavi Solutions pre-market up 23.00%
I'm LongbridgeAI, I can summarize articles.Rising Dragon Acquisition pre-market down 24.82%; Viavi Solutions pre-market up 23.00%; Abits pre-market up 47.87%; American Rebel pre-market up 38.78%; OSR pre-market up 34.57%
Pre-market Hot Trades in US Stocks
Rising Dragon Acquisition, down 24.82% in pre-market, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
VIAV up 23% in pre-market. Based on recent key news:
-
On April 30, Viavi Solutions announced its third-quarter financial report, exceeding analyst expectations. Net income reached $406.8 million, a year-on-year increase of 42.8%, with a non-GAAP earnings per share of $0.27, up 80% year-on-year. This performance drove the stock price up 25.17%. Source: Reuters
-
On April 27, Viavi announced an investment in a PCIe 7.0 protocol analysis testing platform, demonstrating its ongoing commitment to industry innovation. This move enhanced market confidence in the company's future growth. Source: PR Newswire
-
On April 30, analysts maintained a "buy" rating, with a target price slightly below the current stock price, reflecting the market's continued optimism about Viavi. Source: Reuters The demand in the communications industry is strong, and the macroeconomic environment is stable.
Top Gainers in Pre-market US Stocks
Abits up 47.87% in pre-market. Based on recent key news:
-
On April 29, Abits Group Inc released its full-year performance report for 2025, with revenue growth of 37%, and expanded its Bitcoin mining business to a total computing power of 760 PH/s. This news boosted market confidence, driving the stock price up.
-
On April 29, Abits Group Inc submitted its annual report for fiscal year 2025 to the U.S. Securities and Exchange Commission, detailing the company's operations in Bitcoin mining and hosting services. This move further enhanced investors' expectations for the company's future development.
-
On April 30, Abits Group closed down 8.26% during regular trading hours, but the stock price rebounded significantly in pre-market trading, showing the market's optimistic attitude towards the company's long-term prospects. The Bitcoin mining industry has performed strongly recently, with clear capital inflows.
American Rebel up 38.78% in pre-market. Based on recent key news:
-
On April 27, American Rebel Holdings announced the resumption of trading on Nasdaq and provided an update to shareholders. This news boosted market confidence, driving the stock price up.
-
On April 28, American Rebel Holdings reached an agreement with Streeterville to convert its E-series preferred stock into common stock, with a total value of $565,500. This move aims to simplify the capital structure and address preferred stock obligations, further enhancing investor confidence On April 29th, the company released relevant documents on the SEC, detailing the specifics of the aforementioned transaction. The further transparency in information disclosure helps stabilize market expectations. The U.S. stock market has recently seen increased volatility, and investors should exercise caution.
OSR rose 34.57% in pre-market trading. Based on recent news,
-
On April 29th, OSR Holdings signed a global licensing agreement worth $815 million with BCM Europe. This agreement involves the global licensing of VXM01, significantly driving up OSR's stock price.
-
On April 29th, OSR Holdings issued a press release emphasizing the significance of the agreement and its potential market impact. The positive reaction from investors to this agreement further boosted the stock price.
-
On April 29th, OSR Holdings mentioned in the press release that the agreement may face clinical, regulatory, and market risks, but this did not prevent the stock price from rising. Investors remain optimistic about the long-term potential of the agreement. The market maintains an optimistic outlook on the biotechnology industry
